本文選題：貴州　切入點(diǎn)：醫(yī)藥制造企業(yè)　出處：《貴州大學(xué)》2014年碩士論文　論文類型：學(xué)位論文

【摘要】：隨著我國經(jīng)濟(jì)對(duì)外開放的進(jìn)一步發(fā)展，國外眾多醫(yī)藥制造企業(yè)開始進(jìn)入我國市場，國內(nèi)醫(yī)藥制造企業(yè)面臨著國內(nèi)外雙重競爭壓力。貴州經(jīng)濟(jì)發(fā)展正處于高速發(fā)展時(shí)期，而醫(yī)藥制造業(yè)作為貴州的重點(diǎn)產(chǎn)業(yè)之一，要及時(shí)抓住發(fā)展機(jī)遇，提高市場競爭能力。本研究先從貴州醫(yī)藥制造企業(yè)發(fā)展的背景出發(fā)，得出其提高市場競爭力的必要性；然后對(duì)醫(yī)藥產(chǎn)業(yè)、醫(yī)藥制造企業(yè)以及市場競爭力的相關(guān)研究進(jìn)行理論研究。在相關(guān)理論的研究基礎(chǔ)上，搜集相關(guān)的統(tǒng)計(jì)數(shù)據(jù)；運(yùn)用比較分析、規(guī)范分析、定性與定量分析等相關(guān)方法；結(jié)合貴州醫(yī)藥產(chǎn)業(yè)發(fā)展政策，，從研發(fā)能力、市場競爭能力等構(gòu)成要素方面；分析貴州醫(yī)藥制造企業(yè)發(fā)展的現(xiàn)狀。在綜合理論、現(xiàn)狀分析的基礎(chǔ)上，結(jié)合國內(nèi)外關(guān)于醫(yī)藥制造行業(yè)或企業(yè)市場競爭力相關(guān)研究論述；構(gòu)建出貴州醫(yī)藥制造企業(yè)市場競爭力評(píng)價(jià)指標(biāo)體系。進(jìn)一步運(yùn)用因子分析、主成分分析等實(shí)證方法，搜集相關(guān)的數(shù)據(jù)，對(duì)貴州醫(yī)藥制造企業(yè)的市場競爭力作實(shí)證研究。對(duì)貴州醫(yī)藥制造企業(yè)從2005年——2012年近8年的發(fā)展?fàn)顩r作市場競爭力動(dòng)態(tài)分析；取2011年較為完整的截面數(shù)據(jù)作總體評(píng)價(jià)研究；分別對(duì)中成藥生產(chǎn)企業(yè)、中藥飲片加工企業(yè)、化學(xué)藥品制劑制造企業(yè)、生物藥品制造企業(yè)以及貴州醫(yī)藥制造龍頭企業(yè)市場競爭力進(jìn)行分析。最后在實(shí)證分析結(jié)論的基礎(chǔ)上，結(jié)合相關(guān)理論以及發(fā)展現(xiàn)狀，從研發(fā)資金獲取、企業(yè)自主創(chuàng)新能力、知識(shí)產(chǎn)權(quán)保護(hù)、營銷組合策略、創(chuàng)新網(wǎng)絡(luò)等角度提出提升貴州醫(yī)藥制造企業(yè)市場競爭力的對(duì)策建議。
[Abstract]:With the further development of China's economic opening to the outside world, many foreign pharmaceutical manufacturing enterprises have begun to enter the Chinese market, and domestic pharmaceutical manufacturing enterprises are facing double competitive pressures at home and abroad. The economic development of Guizhou is in a period of rapid development. As one of the key industries in Guizhou, the pharmaceutical manufacturing industry should seize the development opportunity in time and improve the market competition ability. Firstly, this study starts from the background of the development of Guizhou pharmaceutical manufacturing enterprises and finds out the necessity of improving the market competitiveness. Then the relevant research on pharmaceutical industry, pharmaceutical manufacturing enterprises and market competitiveness is carried out theoretically. On the basis of relevant theoretical research, relevant statistical data are collected, and comparative analysis is used to standardize the analysis. Qualitative and quantitative analysis and other relevant methods; combined with Guizhou pharmaceutical industry development policy, from the research and development ability, market competitiveness and other elements; analysis of the current situation of Guizhou pharmaceutical manufacturing enterprises. On the basis of comprehensive theory, current situation analysis, Combined with domestic and international research on the market competitiveness of pharmaceutical manufacturing industry or enterprises, the paper constructs the evaluation index system of Guizhou pharmaceutical manufacturing enterprises' market competitiveness, and further uses empirical methods such as factor analysis, principal component analysis, etc. To collect relevant data, to make an empirical study on the market competitiveness of Guizhou pharmaceutical manufacturing enterprises, and to make a dynamic analysis of the market competitiveness of Guizhou pharmaceutical manufacturing enterprises during the past eight years from 2005 to 2012. Taking the complete cross-section data of 2011 as the overall evaluation research, respectively, to the Chinese patent medicine production enterprises, the Chinese medicine pieces processing enterprises, the chemical drug preparation manufacturing enterprises, The market competitiveness of biopharmaceutical manufacturing enterprises and Guizhou leading pharmaceutical manufacturing enterprises is analyzed. Finally, on the basis of empirical analysis conclusion, combining with relevant theories and development status, we obtain R & D funds and enterprises' independent innovation ability. From the aspects of intellectual property protection, marketing combination strategy, innovation network and so on, the countermeasures and suggestions are put forward to enhance the market competitiveness of Guizhou pharmaceutical manufacturing enterprises.
【學(xué)位授予單位】：貴州大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2014
【分類號(hào)】：F426.72;F271

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 劉程惠;胡文忠;何煜波;姜愛麗;徐國凱;;中華民族醫(yī)藥——蒙藥的發(fā)展歷史與研究進(jìn)展[J];安徽農(nóng)業(yè)科學(xué);2012年22期

2 孫杰,張銳,許陶;經(jīng)濟(jì)全球化背景下的中國醫(yī)藥產(chǎn)業(yè)的發(fā)展策略[J];商業(yè)研究;2005年04期

3 馮英娟;鄒明;;吉林省醫(yī)藥產(chǎn)業(yè)競爭力提升對(duì)策研究[J];長春理工大學(xué)學(xué)報(bào)(社會(huì)科學(xué)版);2012年07期

4 李海艦,聶輝華;企業(yè)的競爭優(yōu)勢(shì)來源及其戰(zhàn)略選擇[J];中國工業(yè)經(jīng)濟(jì);2002年09期

5 劉野;錢欣;;基于主成分分析的貴州醫(yī)藥行業(yè)競爭力分析及經(jīng)營績效評(píng)價(jià)[J];經(jīng)營管理者;2010年20期

6 姚霞;;推進(jìn)我國醫(yī)藥行業(yè)兼并重組的政策選擇[J];中國醫(yī)藥科學(xué);2013年18期

7 吳淑艷;;科技型企業(yè)核心競爭力的培育與構(gòu)建[J];產(chǎn)業(yè)與科技論壇;2014年01期

8 張化堯;李德?lián)P;;我國醫(yī)藥制造業(yè)低創(chuàng)新能力原因分析[J];經(jīng)濟(jì)論壇;2012年02期

9 陳春發(fā);朱意;;中國醫(yī)藥制造企業(yè)盈利能力與影響因素的實(shí)證研究[J];經(jīng)濟(jì)體制改革;2008年03期

10 王東梅;張金隆;;湖北省醫(yī)藥產(chǎn)業(yè)發(fā)展的現(xiàn)狀及對(duì)策分析[J];科技進(jìn)步與對(duì)策;2008年12期

本文編號(hào)：1611011